InvestorsHub Logo
Followers 117
Posts 20161
Boards Moderated 0
Alias Born 06/13/2011

Re: Amatuer17 post# 91

Tuesday, 11/26/2019 10:49:25 AM

Tuesday, November 26, 2019 10:49:25 AM

Post# of 1469
This is what we are waiting for ...from recent CC

The company currently expects to announce results in the fourth quarter of 2019 from the PHREEDOM clinical trial, the company's second Phase 3 clinical trial evaluating tenapanor as a monotherapy treatment for hyperphosphatemia in patients with chronic kidney disease (CKD) who are on dialysis.


Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ARDX News